Ke‐Neng Chen
Impact in
-
- Cancer-related molecular mechanisms research
-
- Cancer-related gene regulation
- Developmental Biology and Gene Regulation
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Genomics, phytochemicals, and oxidative stress
Papers in
- Surgery 16
- Esophageal Cancer Research and Treatment 15
-
- Lung Cancer Treatments and Mutations 4
- Gastric Cancer Management and Outcomes 3
- Co-authors
- Luyan Shen (11 shared papers)Wanpu Yan (14 shared papers)Xiaozheng Kang (8 shared papers)Yao Lin (5 shared papers)Simin Li (1 shared paper)Qi Shi (4 shared papers)Bin Dong (4 shared papers)Xiaotian Shi (1 shared paper)
- Journals
- Annals of Surgical Oncology (3 papers)Journal of Clinical Oncology (2 papers)Thoracic Cancer (10 papers)BMJ Open (1 paper)Cancer Science (1 paper)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Ke‐Neng Chen
34 papers receiving 695 citations
Ke‐Neng Chen's Hit Papers
Peers
Comparison fields: 5 of 60
- Cancer Research 139
- Molecular Biology 316
- Pulmonary and Respiratory Medicine 114
- Oncology 83
- Surgery 134
Countries citing papers authored by Ke‐Neng Chen
This map shows the geographic impact of Ke‐Neng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke‐Neng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke‐Neng Chen more than expected).
Fields of papers citing papers by Ke‐Neng Chen
This network shows the impact of papers produced by Ke‐Neng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke‐Neng Chen. The network helps show where Ke‐Neng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke‐Neng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer Hit paper breakdown → | 2025 | 73 |
| 2 | 2018 | 71 | |
| 3 | 2009 | 58 | |
| 4 | 2005 | 57 | |
| 5 | 2018 | 39 | |
| 6 | 2014 | 34 | |
| 7 | 2014 | 34 | |
| 8 | Neoadjuvant Osimertinib for Resectable EGFR -Mutated Non–Small Cell Lung Cancer Hit paper breakdown → | 2025 | 29 |
| 9 | Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma. | 2019 | 27 |
| 10 | 2019 | 26 | |
| 11 | 2018 | 25 | |
| 12 | 2025 | 23 | |
| 13 | 2015 | 21 | |
| 14 | 2015 | 20 | |
| 15 | 2015 | 19 | |
| 16 | 2024 | 18 | |
| 17 | 2018 | 17 | |
| 18 | 2015 | 14 | |
| 19 | 2018 | 14 | |
| 20 | 2021 | 14 |
About Ke‐Neng Chen
Ke‐Neng Chen is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Gastroenterology, having authored 38 papers that have together received 702 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (15 papers), Developmental Biology and Gene Regulation (4 papers), Lung Cancer Treatments and Mutations (4 papers), Gastric Cancer Management and Outcomes (3 papers), Cancer-related gene regulation (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (139 citations), Molecular Biology (316 citations), Pulmonary and Respiratory Medicine (114 citations), Oncology (83 citations) and Surgery (134 citations). Ke‐Neng Chen has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Luyan Shen, Wanpu Yan, Xiaozheng Kang, Yao Lin, Simin Li, Qi Shi, Bin Dong, Xiaotian Shi, Ke Yang and Guang‐wei Xu. Their work appears in journals such as Annals of Surgical Oncology, Journal of Clinical Oncology, Thoracic Cancer, BMJ Open and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.